This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Wen-Kai Weng
Introduction
Wen-Kai Weng is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of medical research, particularly in the area of cancer therapy. His work focuses on improving the effectiveness of antibody therapies for patients suffering from neoplastic conditions.
Latest Patents
Weng holds a patent titled "Methods and compositions for determining responsiveness to antibody therapy." This patent outlines methods and compositions that help determine whether a subject with a neoplastic condition is responsive to antineoplastic therapies, such as antibody therapy, specifically Rituximab. The methods involve genotyping the subject to identify favorable FcγR polymorphisms, such as the 131 H/H genotype or the 158 V/V genotype. Additionally, the patent includes reagents, devices, and kits that facilitate the application of these methods.
Career Highlights
Wen-Kai Weng is affiliated with Leland Stanford Junior University, where he conducts research and develops innovative solutions in the field of cancer treatment. His work has the potential to significantly impact patient outcomes by personalizing therapy based on genetic markers.
Collaborations
Weng collaborates with Ronald Levy, a fellow researcher in the field. Their combined expertise enhances the development of effective cancer therapies and contributes to advancing medical science.
Conclusion
Wen-Kai Weng's contributions to the field of cancer therapy through his innovative patent demonstrate his commitment to improving patient care. His work exemplifies the importance of research and collaboration in the fight against cancer.